Magnetar Financial’s Terns Pharmaceuticals TERN Stock Holding History

Magnetar Financial’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-281,614	Closed	-$14.8M	–	1456
2026 Q1	$14.8M	Buy	+281,614	New	+$11.6M	0.15%	87

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Magnetar Financial's TERN Position: Q2 2026 in Review

Magnetar Financial sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 281,614 shares — an estimated $14.8M sold.

Magnetar Financial first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $14.8M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Magnetar Financial reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Magnetar Financial sold 281,614 Terns Pharmaceuticals shares in Q2 2026, an estimated $14.8M.
Magnetar Financial first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Magnetar Financial's Terns Pharmaceuticals position peaked at $14.8M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Magnetar Financial's 13F filing for Q2 2026, filed 14 Aug 2026.